Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5541 USD | -0.18% | -0.18% | -44.59% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Mesenchymal and Other Stem Cell and Cell-derived Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
William Bossung
BRD | Director/Board Member | - | 23-08-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
William Bossung
BRD | Director/Board Member | - | 18-12-02 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,225,376 | 2,411,070 ( 23.58 %) | 0 | 23.58 % |
Company contact information
Yulong Eco-Materials Ltd.
1621 Central Avenue
82001, Cheyenne
+206-734-4738
http://www.yulongecomaterials.comSector
1st Jan change | Capi. | |
---|---|---|
-44.59% | 5.67M | |
+21.15% | 50.14B | |
+0.55% | 16.36B | |
-17.79% | 13.22B | |
-8.99% | 11.27B | |
-5.16% | 7.67B | |
+39.36% | 7.66B | |
+10.77% | 7.62B | |
+105.28% | 7.41B | |
-15.27% | 6.77B |
- Stock Market
- Equities
- YECO Stock
- Company EV Biologics, Inc.